Phase I study of maytansine using a 3-day schedule.
Fernando Cabanillas(University of Puerto Rico, Medical Sciences Campus), Emil J. Freireich(Unknown), V. Rodríguez(The University of Texas System), M. A. Burgess, S. W. Hall(The University of Texas MD Anderson Cancer Center), G. P. Bodey(The University of Texas MD Anderson Cancer Center)
PubMed
March 1, 1978
Cited by 29
Related Papers
Liposomal Amphotericin B for the Treatment of Systemic Fungal Infections in Patients with Cancer: A Preliminary Study
|The Journal of Infectious Diseases|1985|408
Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia
|Blood|2010|399
Pseudomonas bacteremia. Retrospective analysis of 410 episodes
|Archives of Internal Medicine|1985|361
Systemic candidiasis in cancer patients.
|PubMed|1984|272
Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia.
|Journal of Clinical Oncology|1991|249